IGF2 and chronic kidney disease: Reducing the expression of RTN3 activated the IGF2-JAK2-STAT3 pathway by altering the localization of GC-rich promoter binding protein 1 (GPBP1), increasing the expression of collagen and disrupting the structure and function of mitochondria, which ultimately resulted in CKD and kidney fibrosis.